speb/financial-data huggingface dataset:
CRMT cash_flow (annual, 2025-04-30) — Beginning Cash Position: 94447000.00
CRMT cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 126358000.00
CRMT balance_sheet (annual, 2025-04-30) — Buildings And Improvements: 23575000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Buildings And Improvements: 23575000.00
CRMT cash_flow (annual, 2025-04-30) — Capital Expenditure: -3890000.00
CRMT cash_flow (quarterly, 2025-04-30) — Capital Expenditure: -801000.00
CRMT balance_sheet (annual, 2025-04-30) — Capital Lease Obligations: 67002000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Capital Lease Obligations: 67002000.00
CRMT balance_sheet (annual, 2025-04-30) — Capital Stock: 556000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Capital Stock: 556000.00
CRMT balance_sheet (annual, 2025-04-30) — Cash And Cash Equivalents: 9808000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 9808000.00
CRMT balance_sheet (annual, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 9808000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 9808000.00
CRMT cash_flow (annual, 2025-04-30) — Cash Dividends Paid: -40000.00
CRMT cash_flow (quarterly, 2025-04-30) — Cash Dividends Paid: -10000.00
CRMT cash_flow (annual, 2025-04-30) — Cash Flow From Continuing Financing Activities: 90229000.00
CRMT cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: -20256000.00
CRMT cash_flow (annual, 2025-04-30) — Cash Flow From Continuing Investing Activities: -11375000.00
CRMT cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Investing Activities: -783000.00
CRMT cash_flow (annual, 2025-04-30) — Cash Flow From Continuing Operating Activities: -48764000.00
CRMT cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: 19218000.00
CRMT cash_flow (annual, 2025-04-30) — Change In Inventory: 114573000.00
CRMT cash_flow (quarterly, 2025-04-30) — Change In Inventory: 61243000.00
CRMT cash_flow (annual, 2025-04-30) — Change In Other Working Capital: -3127000.00
CRMT cash_flow (quarterly, 2025-04-30) — Change In Other Working Capital: 6669000.00
CRMT cash_flow (annual, 2025-04-30) — Change In Payables And Accrued Expense: 17616000.00
CRMT cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: 1551000.00
CRMT cash_flow (annual, 2025-04-30) — Change In Prepaid Assets: -6806000.00
CRMT cash_flow (quarterly, 2025-04-30) — Change In Prepaid Assets: -395000.00
CRMT cash_flow (annual, 2025-04-30) — Change In Receivables: -606226000.00
CRMT cash_flow (quarterly, 2025-04-30) — Change In Receivables: -165800000.00
CRMT cash_flow (annual, 2025-04-30) — Change In Working Capital: -483970000.00
CRMT cash_flow (quarterly, 2025-04-30) — Change In Working Capital: -96732000.00
CRMT cash_flow (annual, 2025-04-30) — Changes In Account Receivables: -605701000.00
CRMT cash_flow (quarterly, 2025-04-30) — Changes In Account Receivables: -165424000.00
CRMT cash_flow (annual, 2025-04-30) — Changes In Cash: 30090000.00
CRMT cash_flow (quarterly, 2025-04-30) — Changes In Cash: -1821000.00
CRMT balance_sheet (annual, 2025-04-30) — Common Stock: 156000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Common Stock: 156000.00
CRMT cash_flow (annual, 2025-04-30) — Common Stock Dividend Paid: -40000.00
CRMT cash_flow (quarterly, 2025-04-30) — Common Stock Dividend Paid: -10000.00
CRMT balance_sheet (annual, 2025-04-30) — Common Stock Equity: 569422000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 569422000.00
CRMT cash_flow (annual, 2025-04-30) — Common Stock Issuance: 74106000.00
CRMT cash_flow (quarterly, 2025-04-30) — Common Stock Issuance: 65000.00
CRMT cash_flow (annual, 2025-04-30) — Common Stock Payments: -434000.00
CRMT cash_flow (quarterly, 2025-04-30) — Common Stock Payments: -2000.00
CRMT balance_sheet (annual, 2025-04-30) — Construction In Progress: 1028000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Construction In Progress: 1028000.00
CRMT income_statement (annual, 2025-04-30) — Cost Of Revenue: 726055000.00
CRMT income_statement (quarterly, 2025-04-30) — Cost Of Revenue: 196896000.00
CRMT balance_sheet (annual, 2025-04-30) — Current Accrued Expenses: 10699000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Current Accrued Expenses: 10699000.00
CRMT balance_sheet (annual, 2025-04-30) — Current Assets: 1424871000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Current Assets: 1424871000.00
CRMT balance_sheet (annual, 2025-04-30) — Current Debt: 206058000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Current Debt: 206058000.00
CRMT balance_sheet (annual, 2025-04-30) — Current Debt And Capital Lease Obligation: 206058000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Current Debt And Capital Lease Obligation: 206058000.00
CRMT balance_sheet (annual, 2025-04-30) — Current Deferred Liabilities: 117445000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Current Deferred Liabilities: 117445000.00
CRMT balance_sheet (annual, 2025-04-30) — Current Deferred Revenue: 117445000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Current Deferred Revenue: 117445000.00
CRMT balance_sheet (annual, 2025-04-30) — Current Liabilities: 372085000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 372085000.00
CRMT cash_flow (annual, 2025-04-30) — Deferred Income Tax: -10662000.00
CRMT cash_flow (quarterly, 2025-04-30) — Deferred Income Tax: -2316000.00
CRMT cash_flow (annual, 2025-04-30) — Deferred Tax: -10662000.00
CRMT cash_flow (quarterly, 2025-04-30) — Deferred Tax: -2316000.00
CRMT cash_flow (annual, 2025-04-30) — Depreciation Amortization Depletion: 7647000.00
CRMT cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 1947000.00
CRMT income_statement (annual, 2025-04-30) — Depreciation Amortization Depletion Income Statement: 7647000.00
CRMT income_statement (quarterly, 2025-04-30) — Depreciation Amortization Depletion Income Statement: 1947000.00
CRMT cash_flow (annual, 2025-04-30) — Depreciation And Amortization: 7647000.00
CRMT cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 1947000.00
CRMT income_statement (annual, 2025-04-30) — Depreciation And Amortization In Income Statement: 7647000.00
CRMT income_statement (quarterly, 2025-04-30) — Depreciation And Amortization In Income Statement: 1947000.00
CRMT income_statement (annual, 2025-04-30) — Diluted Average Shares: 7681590.00
CRMT income_statement (quarterly, 2025-04-30) — Diluted Average Shares: 8428197.00
CRMT income_statement (annual, 2025-04-30) — Diluted EPS: 2.33
CRMT income_statement (quarterly, 2025-04-30) — Diluted EPS: 1.26
CRMT income_statement (annual, 2025-04-30) — Diluted NI Availto Com Stockholders: 17892000.00
CRMT income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: 10625000.00
CRMT income_statement (annual, 2025-04-30) — EBIT: 93451000.00
CRMT income_statement (quarterly, 2025-04-30) — EBIT: 29851000.00
CRMT income_statement (annual, 2025-04-30) — EBITDA: 101098000.00
CRMT income_statement (quarterly, 2025-04-30) — EBITDA: 31798000.00
CRMT balance_sheet (annual, 2025-04-30) — Employee Benefits: 7983000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Employee Benefits: 7983000.00
CRMT cash_flow (annual, 2025-04-30) — End Cash Position: 124537000.00
CRMT cash_flow (quarterly, 2025-04-30) — End Cash Position: 124537000.00
CRMT cash_flow (annual, 2025-04-30) — Excess Tax Benefit From Stock Based Compensation: 0.00
CRMT cash_flow (quarterly, 2025-04-30) — Excess Tax Benefit From Stock Based Compensation: 0.00
CRMT cash_flow (annual, 2025-04-30) — Financing Cash Flow: 90229000.00
CRMT cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: -20256000.00
CRMT cash_flow (annual, 2025-04-30) — Free Cash Flow: -52654000.00
CRMT cash_flow (quarterly, 2025-04-30) — Free Cash Flow: 18417000.00
CRMT cash_flow (annual, 2025-04-30) — Gain Loss On Sale Of PPE: -2000.00
CRMT cash_flow (quarterly, 2025-04-30) — Gain Loss On Sale Of PPE: -6000.00
CRMT income_statement (annual, 2025-04-30) — Gain On Sale Of Ppe: -299000.00
CRMT income_statement (quarterly, 2025-04-30) — Gain On Sale Of Ppe: -175000.00
CRMT balance_sheet (annual, 2025-04-30) — Goodwill: 22802000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Goodwill: 22802000.00
CRMT balance_sheet (annual, 2025-04-30) — Goodwill And Other Intangible Assets: 22802000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Goodwill And Other Intangible Assets: 22802000.00
CRMT balance_sheet (annual, 2025-04-30) — Gross Accounts Receivable: 1503110000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Gross Accounts Receivable: 1503110000.00
CRMT balance_sheet (annual, 2025-04-30) — Gross PPE: 178031000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Gross PPE: 178031000.00
CRMT income_statement (annual, 2025-04-30) — Gross Profit: 664877000.00
CRMT income_statement (quarterly, 2025-04-30) — Gross Profit: 173278000.00
CRMT cash_flow (annual, 2025-04-30) — Income Tax Paid Supplemental Data: 11132000.00
CRMT balance_sheet (annual, 2025-04-30) — Income Tax Payable: 1451000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Income Tax Payable: 1451000.00
CRMT income_statement (annual, 2025-04-30) — Interest Expense: 70650000.00
CRMT income_statement (quarterly, 2025-04-30) — Interest Expense: 17373000.00
CRMT income_statement (annual, 2025-04-30) — Interest Expense Non Operating: 70650000.00
CRMT income_statement (quarterly, 2025-04-30) — Interest Expense Non Operating: 17373000.00
CRMT cash_flow (annual, 2025-04-30) — Interest Paid Supplemental Data: 70650000.00
CRMT balance_sheet (annual, 2025-04-30) — Interest Payable: 2155000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Interest Payable: 2155000.00
CRMT balance_sheet (annual, 2025-04-30) — Inventory: 112229000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Inventory: 112229000.00
CRMT balance_sheet (annual, 2025-04-30) — Invested Capital: 1347490000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Invested Capital: 1347490000.00
CRMT cash_flow (annual, 2025-04-30) — Investing Cash Flow: -11375000.00
CRMT cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: -783000.00
CRMT cash_flow (annual, 2025-04-30) — Issuance Of Capital Stock: 74106000.00
CRMT cash_flow (quarterly, 2025-04-30) — Issuance Of Capital Stock: 65000.00
CRMT cash_flow (annual, 2025-04-30) — Issuance Of Debt: 1250980000.00
CRMT cash_flow (quarterly, 2025-04-30) — Issuance Of Debt: 141336000.00
CRMT balance_sheet (annual, 2025-04-30) — Land And Improvements: 11998000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Land And Improvements: 11998000.00
CRMT balance_sheet (annual, 2025-04-30) — Leases: 51466000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Leases: 51466000.00
CRMT balance_sheet (annual, 2025-04-30) — Line Of Credit: 206058000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Line Of Credit: 206058000.00
CRMT balance_sheet (annual, 2025-04-30) — Loans Receivable: 663000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Loans Receivable: 663000.00
CRMT balance_sheet (annual, 2025-04-30) — Long Term Capital Lease Obligation: 67002000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Long Term Capital Lease Obligation: 67002000.00
CRMT balance_sheet (annual, 2025-04-30) — Long Term Debt: 572010000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Long Term Debt: 572010000.00
CRMT balance_sheet (annual, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 639012000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 639012000.00
CRMT cash_flow (annual, 2025-04-30) — Long Term Debt Issuance: 1250980000.00
CRMT cash_flow (quarterly, 2025-04-30) — Long Term Debt Issuance: 601091000.00
CRMT cash_flow (annual, 2025-04-30) — Long Term Debt Payments: -1225843000.00
CRMT cash_flow (quarterly, 2025-04-30) — Long Term Debt Payments: -746517000.00
CRMT balance_sheet (annual, 2025-04-30) — Machinery Furniture Equipment: 26139000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Machinery Furniture Equipment: 26139000.00
CRMT balance_sheet (annual, 2025-04-30) — Minority Interest: 100000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Minority Interest: 100000.00
CRMT cash_flow (annual, 2025-04-30) — Net Common Stock Issuance: 73672000.00
CRMT cash_flow (quarterly, 2025-04-30) — Net Common Stock Issuance: 63000.00
CRMT balance_sheet (annual, 2025-04-30) — Net Debt: 768260000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Net Debt: 768260000.00
CRMT income_statement (annual, 2025-04-30) — Net Income: 17932000.00
CRMT income_statement (quarterly, 2025-04-30) — Net Income: 10635000.00
CRMT income_statement (annual, 2025-04-30) — Net Income Common Stockholders: 17892000.00
CRMT income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: 10625000.00
CRMT income_statement (annual, 2025-04-30) — Net Income Continuous Operations: 17932000.00
CRMT income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: 10635000.00
CRMT income_statement (annual, 2025-04-30) — Net Income From Continuing And Discontinued Operation: 17932000.00
CRMT income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: 10635000.00
CRMT income_statement (annual, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: 17932000.00
CRMT income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: 10635000.00
CRMT cash_flow (annual, 2025-04-30) — Net Income From Continuing Operations: 17932000.00
CRMT cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: 10635000.00
CRMT income_statement (annual, 2025-04-30) — Net Income Including Noncontrolling Interests: 17932000.00
CRMT income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: 10635000.00
CRMT income_statement (annual, 2025-04-30) — Net Interest Income: -70650000.00
CRMT income_statement (quarterly, 2025-04-30) — Net Interest Income: -17373000.00
CRMT cash_flow (annual, 2025-04-30) — Net Investment Purchase And Sale: -7527000.00
CRMT cash_flow (quarterly, 2025-04-30) — Net Investment Purchase And Sale: 0.00
CRMT cash_flow (annual, 2025-04-30) — Net Issuance Payments Of Debt: 25603000.00
CRMT cash_flow (quarterly, 2025-04-30) — Net Issuance Payments Of Debt: -18266000.00
CRMT cash_flow (annual, 2025-04-30) — Net Long Term Debt Issuance: 25137000.00
CRMT cash_flow (quarterly, 2025-04-30) — Net Long Term Debt Issuance: -145426000.00
CRMT income_statement (annual, 2025-04-30) — Net Non Operating Interest Income Expense: -70650000.00
CRMT income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: -17373000.00
CRMT cash_flow (annual, 2025-04-30) — Net Other Financing Charges: -9006000.00
CRMT cash_flow (quarterly, 2025-04-30) — Net Other Financing Charges: -2043000.00
CRMT balance_sheet (annual, 2025-04-30) — Net PPE: 120719000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Net PPE: 120719000.00
CRMT cash_flow (annual, 2025-04-30) — Net PPE Purchase And Sale: -3848000.00
CRMT cash_flow (quarterly, 2025-04-30) — Net PPE Purchase And Sale: -783000.00
CRMT cash_flow (annual, 2025-04-30) — Net Short Term Debt Issuance: 466000.00
CRMT cash_flow (quarterly, 2025-04-30) — Net Short Term Debt Issuance: 127160000.00
CRMT balance_sheet (annual, 2025-04-30) — Net Tangible Assets: 547020000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 547020000.00
CRMT balance_sheet (annual, 2025-04-30) — Non Current Deferred Liabilities: 17472000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Liabilities: 17472000.00
CRMT balance_sheet (annual, 2025-04-30) — Non Current Deferred Taxes Liabilities: 17472000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Taxes Liabilities: 17472000.00
CRMT income_statement (annual, 2025-04-30) — Normalized EBITDA: 101397000.00
CRMT income_statement (quarterly, 2025-04-30) — Normalized EBITDA: 31973000.00
CRMT income_statement (annual, 2025-04-30) — Normalized Income: 18167150.56
CRMT income_statement (quarterly, 2025-04-30) — Normalized Income: 10784152.51
CRMT cash_flow (annual, 2025-04-30) — Operating Cash Flow: -48764000.00
CRMT cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: 19218000.00
CRMT cash_flow (annual, 2025-04-30) — Operating Gains Losses: -2000.00
CRMT cash_flow (quarterly, 2025-04-30) — Operating Gains Losses: -6000.00
CRMT income_statement (annual, 2025-04-30) — Operating Income: 93750000.00
CRMT income_statement (quarterly, 2025-04-30) — Operating Income: 30026000.00
CRMT income_statement (annual, 2025-04-30) — Operating Revenue: 1390932000.00
CRMT income_statement (quarterly, 2025-04-30) — Operating Revenue: 370174000.00
CRMT balance_sheet (annual, 2025-04-30) — Ordinary Shares Number: 8263280.00
CRMT balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 8263280.00
CRMT income_statement (annual, 2025-04-30) — Other Income Expense: -299000.00
CRMT income_statement (quarterly, 2025-04-30) — Other Income Expense: -175000.00
CRMT cash_flow (annual, 2025-04-30) — Other Non Cash Items: 40884000.00
CRMT cash_flow (quarterly, 2025-04-30) — Other Non Cash Items: 11785000.00
CRMT balance_sheet (annual, 2025-04-30) — Other Non Current Assets: 38082000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Other Non Current Assets: 38082000.00
CRMT balance_sheet (annual, 2025-04-30) — Other Properties: 63825000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Other Properties: 63825000.00
CRMT balance_sheet (annual, 2025-04-30) — Payables: 37883000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Payables: 37883000.00
CRMT balance_sheet (annual, 2025-04-30) — Payables And Accrued Expenses: 48582000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 48582000.00
CRMT balance_sheet (annual, 2025-04-30) — Preferred Stock: 400000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Preferred Stock: 400000.00
CRMT income_statement (annual, 2025-04-30) — Preferred Stock Dividends: 40000.00
CRMT income_statement (quarterly, 2025-04-30) — Preferred Stock Dividends: 10000.00
CRMT balance_sheet (annual, 2025-04-30) — Preferred Stock Equity: 400000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Preferred Stock Equity: 400000.00
CRMT income_statement (annual, 2025-04-30) — Pretax Income: 22801000.00
CRMT income_statement (quarterly, 2025-04-30) — Pretax Income: 12478000.00
CRMT cash_flow (annual, 2025-04-30) — Proceeds From Stock Option Exercised: 0.00
CRMT cash_flow (quarterly, 2025-04-30) — Proceeds From Stock Option Exercised: 0.00
CRMT balance_sheet (annual, 2025-04-30) — Properties: 0.00
CRMT balance_sheet (quarterly, 2025-04-30) — Properties: 0.00
CRMT income_statement (annual, 2025-04-30) — Provision For Doubtful Accounts: 374559000.00
CRMT income_statement (quarterly, 2025-04-30) — Provision For Doubtful Accounts: 92962000.00
CRMT cash_flow (annual, 2025-04-30) — Provisionand Write Offof Assets: 374559000.00
CRMT cash_flow (quarterly, 2025-04-30) — Provisionand Write Offof Assets: 92962000.00
CRMT cash_flow (annual, 2025-04-30) — Purchase Of Investment: -7527000.00
CRMT cash_flow (quarterly, 2025-04-30) — Purchase Of Investment: 0.00
CRMT cash_flow (annual, 2025-04-30) — Purchase Of PPE: -3890000.00
CRMT cash_flow (quarterly, 2025-04-30) — Purchase Of PPE: -801000.00
CRMT balance_sheet (annual, 2025-04-30) — Receivables: 1188105000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Receivables: 1188105000.00
CRMT income_statement (annual, 2025-04-30) — Reconciled Cost Of Revenue: 726055000.00
CRMT income_statement (quarterly, 2025-04-30) — Reconciled Cost Of Revenue: 196896000.00
CRMT income_statement (annual, 2025-04-30) — Reconciled Depreciation: 7647000.00
CRMT income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 1947000.00
CRMT cash_flow (annual, 2025-04-30) — Repayment Of Debt: -1225843000.00
CRMT cash_flow (quarterly, 2025-04-30) — Repayment Of Debt: -160068000.00
CRMT cash_flow (annual, 2025-04-30) — Repurchase Of Capital Stock: -434000.00
CRMT cash_flow (quarterly, 2025-04-30) — Repurchase Of Capital Stock: -2000.00
CRMT balance_sheet (annual, 2025-04-30) — Restricted Cash: 114729000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Restricted Cash: 114729000.00
CRMT balance_sheet (annual, 2025-04-30) — Retained Earnings: 672261000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Retained Earnings: 672261000.00
CRMT cash_flow (annual, 2025-04-30) — Sale Of PPE: 42000.00
CRMT cash_flow (quarterly, 2025-04-30) — Sale Of PPE: 18000.00
CRMT income_statement (annual, 2025-04-30) — Selling General And Administration: 188921000.00
CRMT income_statement (quarterly, 2025-04-30) — Selling General And Administration: 48343000.00
CRMT balance_sheet (annual, 2025-04-30) — Share Issued: 15605818.00
CRMT balance_sheet (quarterly, 2025-04-30) — Share Issued: 15605818.00
CRMT income_statement (annual, 2025-04-30) — Special Income Charges: -299000.00
CRMT income_statement (quarterly, 2025-04-30) — Special Income Charges: -175000.00
CRMT cash_flow (annual, 2025-04-30) — Stock Based Compensation: 4708000.00
CRMT cash_flow (quarterly, 2025-04-30) — Stock Based Compensation: 923000.00
CRMT balance_sheet (annual, 2025-04-30) — Stockholders Equity: 569822000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 569822000.00
CRMT balance_sheet (annual, 2025-04-30) — Tangible Book Value: 546620000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 546620000.00
CRMT income_statement (annual, 2025-04-30) — Tax Effect Of Unusual Items: -63849.44
CRMT income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: -25847.49
CRMT income_statement (annual, 2025-04-30) — Tax Provision: 4869000.00
CRMT income_statement (quarterly, 2025-04-30) — Tax Provision: 1843000.00
CRMT income_statement (annual, 2025-04-30) — Tax Rate For Calcs: 0.21
CRMT income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.15
CRMT balance_sheet (annual, 2025-04-30) — Taxes Receivable: 0.00
CRMT balance_sheet (quarterly, 2025-04-30) — Taxes Receivable: 0.00
CRMT balance_sheet (annual, 2025-04-30) — Total Assets: 1606474000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Total Assets: 1606474000.00
CRMT balance_sheet (annual, 2025-04-30) — Total Capitalization: 1141832000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 1141832000.00
CRMT balance_sheet (annual, 2025-04-30) — Total Debt: 845070000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Total Debt: 845070000.00
CRMT balance_sheet (annual, 2025-04-30) — Total Equity Gross Minority Interest: 569922000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 569922000.00
CRMT income_statement (annual, 2025-04-30) — Total Expenses: 1297182000.00
CRMT income_statement (quarterly, 2025-04-30) — Total Expenses: 340148000.00
CRMT balance_sheet (annual, 2025-04-30) — Total Liabilities Net Minority Interest: 1036552000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 1036552000.00
CRMT balance_sheet (annual, 2025-04-30) — Total Non Current Assets: 181603000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Total Non Current Assets: 181603000.00
CRMT balance_sheet (annual, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 664467000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 664467000.00
CRMT balance_sheet (annual, 2025-04-30) — Total Tax Payable: 2903000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Total Tax Payable: 2903000.00
CRMT income_statement (annual, 2025-04-30) — Total Unusual Items: -299000.00
CRMT income_statement (quarterly, 2025-04-30) — Total Unusual Items: -175000.00
CRMT income_statement (annual, 2025-04-30) — Total Unusual Items Excluding Goodwill: -299000.00
CRMT income_statement (quarterly, 2025-04-30) — Total Unusual Items Excluding Goodwill: -175000.00
CRMT balance_sheet (annual, 2025-04-30) — Treasury Shares Number: 7342538.00
CRMT balance_sheet (quarterly, 2025-04-30) — Treasury Shares Number: 7342538.00
CRMT balance_sheet (annual, 2025-04-30) — Treasury Stock: 298220000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Treasury Stock: 298220000.00
CRMT balance_sheet (annual, 2025-04-30) — Working Capital: 1052786000.00
CRMT balance_sheet (quarterly, 2025-04-30) — Working Capital: 1052786000.00
CRMT income_statement (annual, 2025-04-30) — Write Off: 0.00
CRMT income_statement (quarterly, 2025-07-31) — +Operating Expense: 156583000.00
CRMT income_statement (quarterly, 2025-07-31) — +Total Revenue: 341312000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Accounts Payable: 33977000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Accounts Receivable: 1182789000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Accrued Interest Receivable: 8145000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Accumulated Depreciation: -59240000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Additional Paid In Capital: 196451000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Allowance For Doubtful Accounts Receivable: -326070000.00
CRMT cash_flow (quarterly, 2025-07-31) — Asset Impairment Charge: 14000.00
CRMT income_statement (quarterly, 2025-07-31) — Basic Average Shares: 8274054.00
CRMT income_statement (quarterly, 2025-07-31) — Basic EPS: -0.69
CRMT cash_flow (quarterly, 2025-07-31) — Beginning Cash Position: 124537000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Buildings And Improvements: 23604000.00
CRMT cash_flow (quarterly, 2025-07-31) — Capital Expenditure: -459000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Capital Lease Obligations: 66948000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Capital Stock: 556000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Cash And Cash Equivalents: 9666000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Cash Cash Equivalents And Short Term Investments: 9666000.00
CRMT cash_flow (quarterly, 2025-07-31) — Cash Dividends Paid: -10000.00
CRMT cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Financing Activities: 3247000.00
CRMT cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Investing Activities: -439000.00
CRMT cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Operating Activities: -5918000.00
CRMT cash_flow (quarterly, 2025-07-31) — Change In Account Payable: 3205000.00
CRMT cash_flow (quarterly, 2025-07-31) — Change In Inventory: 28618000.00
CRMT cash_flow (quarterly, 2025-07-31) — Change In Other Working Capital: -3288000.00
CRMT cash_flow (quarterly, 2025-07-31) — Change In Payable: 3205000.00
CRMT cash_flow (quarterly, 2025-07-31) — Change In Payables And Accrued Expense: 3205000.00
CRMT cash_flow (quarterly, 2025-07-31) — Change In Prepaid Assets: -787000.00
CRMT cash_flow (quarterly, 2025-07-31) — Change In Receivables: -144739000.00
CRMT cash_flow (quarterly, 2025-07-31) — Change In Working Capital: -116991000.00
CRMT cash_flow (quarterly, 2025-07-31) — Changes In Account Receivables: -144026000.00
CRMT cash_flow (quarterly, 2025-07-31) — Changes In Cash: -3110000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Common Stock: 156000.00
CRMT cash_flow (quarterly, 2025-07-31) — Common Stock Dividend Paid: -10000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Common Stock Equity: 564831000.00
CRMT cash_flow (quarterly, 2025-07-31) — Common Stock Issuance: 69000.00
CRMT cash_flow (quarterly, 2025-07-31) — Common Stock Payments: -71000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Construction In Progress: 1115000.00
CRMT income_statement (quarterly, 2025-07-31) — Cost Of Revenue: 175080000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Current Accrued Expenses: 18039000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Current Assets: 1426280000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Current Debt: 171846000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Current Debt And Capital Lease Obligation: 171846000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Current Deferred Liabilities: 112213000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Current Deferred Revenue: 112213000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Current Liabilities: 336075000.00
CRMT cash_flow (quarterly, 2025-07-31) — Deferred Income Tax: 608000.00
CRMT cash_flow (quarterly, 2025-07-31) — Deferred Tax: 608000.00
CRMT cash_flow (quarterly, 2025-07-31) — Depreciation Amortization Depletion: 2139000.00
CRMT income_statement (quarterly, 2025-07-31) — Depreciation Amortization Depletion Income Statement: 2139000.00
CRMT cash_flow (quarterly, 2025-07-31) — Depreciation And Amortization: 2139000.00
CRMT income_statement (quarterly, 2025-07-31) — Depreciation And Amortization In Income Statement: 2139000.00
CRMT income_statement (quarterly, 2025-07-31) — Diluted Average Shares: 8274054.00
CRMT income_statement (quarterly, 2025-07-31) — Diluted EPS: -0.69
CRMT income_statement (quarterly, 2025-07-31) — Diluted NI Availto Com Stockholders: -5746000.00
CRMT income_statement (quarterly, 2025-07-31) — EBIT: 9640000.00
CRMT income_statement (quarterly, 2025-07-31) — EBITDA: 11779000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Employee Benefits: 9704000.00
CRMT cash_flow (quarterly, 2025-07-31) — End Cash Position: 121427000.00
CRMT cash_flow (quarterly, 2025-07-31) — Financing Cash Flow: 3247000.00
CRMT cash_flow (quarterly, 2025-07-31) — Free Cash Flow: -6377000.00
CRMT cash_flow (quarterly, 2025-07-31) — Gain Loss On Sale Of PPE: -9000.00
CRMT income_statement (quarterly, 2025-07-31) — Gain On Sale Of Ppe: -9000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Goodwill: 23695000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Goodwill And Other Intangible Assets: 23695000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Gross Accounts Receivable: 1508859000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Gross PPE: 178003000.00
CRMT income_statement (quarterly, 2025-07-31) — Gross Profit: 166232000.00
CRMT cash_flow (quarterly, 2025-07-31) — Income Tax Paid Supplemental Data: 85000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Income Tax Payable: 0.00
CRMT income_statement (quarterly, 2025-07-31) — Interest Expense: 17042000.00
CRMT income_statement (quarterly, 2025-07-31) — Interest Expense Non Operating: 17042000.00
CRMT cash_flow (quarterly, 2025-07-31) — Interest Paid Supplemental Data: 16850000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Interest Payable: 2347000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Inventory: 112451000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Invested Capital: 1347427000.00
CRMT cash_flow (quarterly, 2025-07-31) — Investing Cash Flow: -439000.00
CRMT cash_flow (quarterly, 2025-07-31) — Issuance Of Capital Stock: 69000.00
CRMT cash_flow (quarterly, 2025-07-31) — Issuance Of Debt: 374571000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Land And Improvements: 11998000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Leases: 51586000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Line Of Credit: 171846000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Loans Receivable: 663000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Long Term Capital Lease Obligation: 66948000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Long Term Debt: 610750000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Long Term Debt And Capital Lease Obligation: 677698000.00
CRMT cash_flow (quarterly, 2025-07-31) — Long Term Debt Issuance: 374571000.00
CRMT cash_flow (quarterly, 2025-07-31) — Long Term Debt Payments: -375766000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Machinery Furniture Equipment: 26140000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Minority Interest: 100000.00
CRMT cash_flow (quarterly, 2025-07-31) — Net Common Stock Issuance: -2000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Net Debt: 772930000.00
CRMT income_statement (quarterly, 2025-07-31) — Net Income: -5736000.00
CRMT income_statement (quarterly, 2025-07-31) — Net Income Common Stockholders: -5746000.00
CRMT income_statement (quarterly, 2025-07-31) — Net Income Continuous Operations: -5736000.00
CRMT income_statement (quarterly, 2025-07-31) — Net Income From Continuing And Discontinued Operation: -5736000.00
CRMT income_statement (quarterly, 2025-07-31) — Net Income From Continuing Operation Net Minority Interest: -5736000.00
CRMT cash_flow (quarterly, 2025-07-31) — Net Income From Continuing Operations: -5736000.00
CRMT income_statement (quarterly, 2025-07-31) — Net Income Including Noncontrolling Interests: -5736000.00
CRMT income_statement (quarterly, 2025-07-31) — Net Interest Income: -17042000.00
CRMT cash_flow (quarterly, 2025-07-31) — Net Investment Purchase And Sale: 0.00
CRMT cash_flow (quarterly, 2025-07-31) — Net Issuance Payments Of Debt: 4967000.00
CRMT cash_flow (quarterly, 2025-07-31) — Net Long Term Debt Issuance: -1195000.00
CRMT income_statement (quarterly, 2025-07-31) — Net Non Operating Interest Income Expense: -17042000.00
CRMT cash_flow (quarterly, 2025-07-31) — Net Other Financing Charges: -1708000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Net PPE: 118763000.00
CRMT cash_flow (quarterly, 2025-07-31) — Net PPE Purchase And Sale: -439000.00
CRMT cash_flow (quarterly, 2025-07-31) — Net Short Term Debt Issuance: 6162000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Net Tangible Assets: 541536000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Liabilities: 19166000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Taxes Liabilities: 19166000.00
CRMT income_statement (quarterly, 2025-07-31) — Normalized EBITDA: 11788000.00
CRMT income_statement (quarterly, 2025-07-31) — Normalized Income: -5729025.67
CRMT cash_flow (quarterly, 2025-07-31) — Operating Cash Flow: -5918000.00
CRMT cash_flow (quarterly, 2025-07-31) — Operating Gains Losses: -9000.00
CRMT income_statement (quarterly, 2025-07-31) — Operating Income: 9649000.00
CRMT income_statement (quarterly, 2025-07-31) — Operating Revenue: 341312000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Ordinary Shares Number: 8277613.00
CRMT income_statement (quarterly, 2025-07-31) — Other Income Expense: -9000.00
CRMT cash_flow (quarterly, 2025-07-31) — Other Non Cash Items: 9864000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Other Non Current Assets: 39236000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Other Properties: 63560000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Payables: 33977000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Payables And Accrued Expenses: 52016000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Preferred Stock: 400000.00
CRMT income_statement (quarterly, 2025-07-31) — Preferred Stock Dividends: 10000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Preferred Stock Equity: 400000.00
CRMT income_statement (quarterly, 2025-07-31) — Pretax Income: -7402000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Properties: 0.00
CRMT income_statement (quarterly, 2025-07-31) — Provision For Doubtful Accounts: 103036000.00
CRMT cash_flow (quarterly, 2025-07-31) — Provisionand Write Offof Assets: 103036000.00
CRMT cash_flow (quarterly, 2025-07-31) — Purchase Of Investment: 0.00
CRMT cash_flow (quarterly, 2025-07-31) — Purchase Of PPE: -459000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Receivables: 1192402000.00
CRMT income_statement (quarterly, 2025-07-31) — Reconciled Cost Of Revenue: 175080000.00
CRMT income_statement (quarterly, 2025-07-31) — Reconciled Depreciation: 2139000.00
CRMT cash_flow (quarterly, 2025-07-31) — Repayment Of Debt: -375766000.00
CRMT cash_flow (quarterly, 2025-07-31) — Repurchase Of Capital Stock: -71000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Restricted Cash: 111761000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Retained Earnings: 666515000.00
CRMT cash_flow (quarterly, 2025-07-31) — Sale Of PPE: 20000.00
CRMT income_statement (quarterly, 2025-07-31) — Selling General And Administration: 51408000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Share Issued: 15621456.00
CRMT income_statement (quarterly, 2025-07-31) — Special Income Charges: -9000.00
CRMT cash_flow (quarterly, 2025-07-31) — Stock Based Compensation: 1157000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Stockholders Equity: 565231000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Tangible Book Value: 541136000.00
CRMT income_statement (quarterly, 2025-07-31) — Tax Effect Of Unusual Items: -2025.67
CRMT income_statement (quarterly, 2025-07-31) — Tax Provision: -1666000.00
CRMT income_statement (quarterly, 2025-07-31) — Tax Rate For Calcs: 0.23
CRMT balance_sheet (quarterly, 2025-07-31) — Taxes Receivable: 805000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Total Assets: 1607974000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Total Capitalization: 1175981000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Total Debt: 849544000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Total Equity Gross Minority Interest: 565331000.00
CRMT income_statement (quarterly, 2025-07-31) — Total Expenses: 331663000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Total Liabilities Net Minority Interest: 1042643000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 181694000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 706568000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Total Tax Payable: 0.00
CRMT income_statement (quarterly, 2025-07-31) — Total Unusual Items: -9000.00
CRMT income_statement (quarterly, 2025-07-31) — Total Unusual Items Excluding Goodwill: -9000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Treasury Shares Number: 7343843.00
CRMT balance_sheet (quarterly, 2025-07-31) — Treasury Stock: 298291000.00
CRMT balance_sheet (quarterly, 2025-07-31) — Working Capital: 1090205000.00
CRMT income_statement (quarterly, 2025-10-31) — +Operating Expense: 178398000.00
CRMT income_statement (quarterly, 2025-10-31) — +Total Revenue: 350192000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 45549000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Accounts Receivable: 1171377000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Accrued Interest Receivable: 7522000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Accumulated Depreciation: -61968000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Additional Paid In Capital: 209333000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Allowance For Doubtful Accounts Receivable: -338827000.00
CRMT cash_flow (quarterly, 2025-10-31) — Asset Impairment Charge: 988000.00
CRMT income_statement (quarterly, 2025-10-31) — Basic Average Shares: 8283116.00
CRMT income_statement (quarterly, 2025-10-31) — Basic EPS: -2.71
CRMT cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 121427000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Buildings And Improvements: 23668000.00
CRMT cash_flow (quarterly, 2025-10-31) — Capital Expenditure: -784000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Capital Lease Obligations: 65820000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Capital Stock: 556000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 122362000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 122362000.00
CRMT cash_flow (quarterly, 2025-10-31) — Cash Dividends Paid: -10000.00
CRMT cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: 121172000.00
CRMT cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: -687000.00
CRMT cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: 9059000.00
CRMT cash_flow (quarterly, 2025-10-31) — Change In Inventory: 39919000.00
CRMT cash_flow (quarterly, 2025-10-31) — Change In Other Working Capital: -9538000.00
CRMT cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: 9543000.00
CRMT cash_flow (quarterly, 2025-10-31) — Change In Prepaid Assets: 1222000.00
CRMT cash_flow (quarterly, 2025-10-31) — Change In Receivables: -147503000.00
CRMT cash_flow (quarterly, 2025-10-31) — Change In Working Capital: -106357000.00
CRMT cash_flow (quarterly, 2025-10-31) — Changes In Account Receivables: -148126000.00
CRMT cash_flow (quarterly, 2025-10-31) — Changes In Cash: 129544000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Common Stock: 156000.00
CRMT cash_flow (quarterly, 2025-10-31) — Common Stock Dividend Paid: -10000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 555026000.00
CRMT cash_flow (quarterly, 2025-10-31) — Common Stock Issuance: 51000.00
CRMT cash_flow (quarterly, 2025-10-31) — Common Stock Payments: -205000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Construction In Progress: 1561000.00
CRMT income_statement (quarterly, 2025-10-31) — Cost Of Revenue: 179016000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Current Accrued Expenses: 16220000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Current Assets: 1542973000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Current Debt: 261912000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Current Debt And Capital Lease Obligation: 261912000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Current Deferred Liabilities: 109575000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Current Deferred Revenue: 109575000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 434960000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Current Notes Payable: 261912000.00
CRMT cash_flow (quarterly, 2025-10-31) — Deferred Income Tax: 0.00
CRMT cash_flow (quarterly, 2025-10-31) — Deferred Tax: 0.00
CRMT cash_flow (quarterly, 2025-10-31) — Depreciation Amortization Depletion: 2102000.00
CRMT income_statement (quarterly, 2025-10-31) — Depreciation Amortization Depletion Income Statement: 2102000.00
CRMT cash_flow (quarterly, 2025-10-31) — Depreciation And Amortization: 2102000.00
CRMT income_statement (quarterly, 2025-10-31) — Depreciation And Amortization In Income Statement: 2102000.00
CRMT income_statement (quarterly, 2025-10-31) — Diluted Average Shares: 8283116.00
CRMT income_statement (quarterly, 2025-10-31) — Diluted EPS: -2.71
CRMT income_statement (quarterly, 2025-10-31) — Diluted NI Availto Com Stockholders: -22482000.00
CRMT income_statement (quarterly, 2025-10-31) — EBIT: -11798000.00
CRMT income_statement (quarterly, 2025-10-31) — EBITDA: -9696000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Employee Benefits: 8446000.00
CRMT cash_flow (quarterly, 2025-10-31) — End Cash Position: 250971000.00
CRMT cash_flow (quarterly, 2025-10-31) — Financing Cash Flow: 121172000.00
CRMT cash_flow (quarterly, 2025-10-31) — Free Cash Flow: 8275000.00
CRMT cash_flow (quarterly, 2025-10-31) — Gain Loss On Sale Of PPE: 9000.00
CRMT income_statement (quarterly, 2025-10-31) — Gain On Sale Of Ppe: -100000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Goodwill: 23685000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Goodwill And Other Intangible Assets: 23685000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Gross Accounts Receivable: 1510204000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Gross PPE: 175997000.00
CRMT income_statement (quarterly, 2025-10-31) — Gross Profit: 171176000.00
CRMT cash_flow (quarterly, 2025-10-31) — Income Tax Paid Supplemental Data: 1777000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Income Tax Payable: 0.00
CRMT income_statement (quarterly, 2025-10-31) — Interest Expense: 15685000.00
CRMT income_statement (quarterly, 2025-10-31) — Interest Expense Non Operating: 15685000.00
CRMT cash_flow (quarterly, 2025-10-31) — Interest Paid Supplemental Data: 18411000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Interest Payable: 1213000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Inventory: 104751000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Invested Capital: 1451972000.00
CRMT cash_flow (quarterly, 2025-10-31) — Investing Cash Flow: -687000.00
CRMT cash_flow (quarterly, 2025-10-31) — Issuance Of Capital Stock: 51000.00
CRMT cash_flow (quarterly, 2025-10-31) — Issuance Of Debt: 615982000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Land And Improvements: 11998000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Leases: 51132000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Line Of Credit: 0.00
CRMT balance_sheet (quarterly, 2025-10-31) — Loans Receivable: 648000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Long Term Capital Lease Obligation: 65820000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Long Term Debt: 635034000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 700854000.00
CRMT cash_flow (quarterly, 2025-10-31) — Long Term Debt Issuance: 615982000.00
CRMT cash_flow (quarterly, 2025-10-31) — Long Term Debt Payments: -471143000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Machinery Furniture Equipment: 26137000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Minority Interest: 100000.00
CRMT cash_flow (quarterly, 2025-10-31) — Net Common Stock Issuance: -154000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Net Debt: 774584000.00
CRMT income_statement (quarterly, 2025-10-31) — Net Income: -22472000.00
CRMT income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: -22482000.00
CRMT income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: -22472000.00
CRMT income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: -22472000.00
CRMT income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: -22472000.00
CRMT cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: -22472000.00
CRMT income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: -22472000.00
CRMT income_statement (quarterly, 2025-10-31) — Net Interest Income: -15685000.00
CRMT cash_flow (quarterly, 2025-10-31) — Net Issuance Payments Of Debt: 137388000.00
CRMT cash_flow (quarterly, 2025-10-31) — Net Long Term Debt Issuance: 144839000.00
CRMT income_statement (quarterly, 2025-10-31) — Net Non Operating Interest Income Expense: -15685000.00
CRMT cash_flow (quarterly, 2025-10-31) — Net Other Financing Charges: -16052000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Net PPE: 114029000.00
CRMT cash_flow (quarterly, 2025-10-31) — Net PPE Purchase And Sale: -687000.00
CRMT cash_flow (quarterly, 2025-10-31) — Net Short Term Debt Issuance: -7451000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: 531741000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Liabilities: 18134000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Non Current Deferred Taxes Liabilities: 18134000.00
CRMT income_statement (quarterly, 2025-10-31) — Normalized EBITDA: -5120000.00
CRMT income_statement (quarterly, 2025-10-31) — Normalized Income: -18730346.18
CRMT cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: 9059000.00
CRMT cash_flow (quarterly, 2025-10-31) — Operating Gains Losses: 2735000.00
CRMT income_statement (quarterly, 2025-10-31) — Operating Income: -7222000.00
CRMT income_statement (quarterly, 2025-10-31) — Operating Revenue: 350192000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 8294520.00
CRMT income_statement (quarterly, 2025-10-31) — Other Income Expense: -4576000.00
CRMT cash_flow (quarterly, 2025-10-31) — Other Non Cash Items: 11801000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Other Non Current Assets: 37233000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Other Properties: 61501000.00
CRMT income_statement (quarterly, 2025-10-31) — Other Special Charges: 4476000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Payables: 47253000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 63473000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Preferred Stock: 400000.00
CRMT income_statement (quarterly, 2025-10-31) — Preferred Stock Dividends: 10000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Preferred Stock Equity: 400000.00
CRMT income_statement (quarterly, 2025-10-31) — Pretax Income: -27483000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Properties: 0.00
CRMT income_statement (quarterly, 2025-10-31) — Provision For Doubtful Accounts: 119074000.00
CRMT cash_flow (quarterly, 2025-10-31) — Provisionand Write Offof Assets: 119073000.00
CRMT cash_flow (quarterly, 2025-10-31) — Purchase Of PPE: -784000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Receivables: 1187251000.00
CRMT income_statement (quarterly, 2025-10-31) — Reconciled Cost Of Revenue: 179016000.00
CRMT income_statement (quarterly, 2025-10-31) — Reconciled Depreciation: 2102000.00
CRMT cash_flow (quarterly, 2025-10-31) — Repayment Of Debt: -471143000.00
CRMT cash_flow (quarterly, 2025-10-31) — Repurchase Of Capital Stock: -205000.00
CRMT balance_sheet (quarterly, 2025-10-31) — Restricted Cash: 128609000.00